Journal article 839 views
In Vitro Inhibition of Human Aldehyde Oxidase Activity by Clinically Relevant Concentrations of Gefitinib and Erlotinib: Comparison with Select Metabolites, Molecular Docking Analysis, and Impact on Hepatic Metabolism of Zaleplon...
Wee Kiat Tan,
Alyssa Rui Yi Tan,
Punitha Sivanandam,
Ernest Jing Hui Goh,
Ze Ping Yap,
Nur Fazilah Saburulla,
Karl Austin-Muttitt,
Jonathan Mullins ,
Aik Jiang Lau
Journal of Pharmacology and Experimental Therapeutics, Volume: 374, Issue: 2, Pages: 295 - 307
Swansea University Authors: Karl Austin-Muttitt, Jonathan Mullins
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1124/jpet.120.265249
Abstract
In Vitro Inhibition of Human Aldehyde Oxidase Activity by Clinically Relevant Concentrations of Gefitinib and Erlotinib: Comparison with Select Metabolites, Molecular Docking Analysis, and Impact on Hepatic Metabolism of Zaleplon and Methotrexate
Published in: | Journal of Pharmacology and Experimental Therapeutics |
---|---|
ISSN: | 0022-3565 1521-0103 |
Published: |
American Society for Pharmacology & Experimental Therapeutics (ASPET)
2020
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa55640 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
College: |
Faculty of Medicine, Health and Life Sciences |
---|---|
Issue: |
2 |
Start Page: |
295 |
End Page: |
307 |